de Tute, Ruth
Counsell, Nicholas http://orcid.org/0000-0002-0688-9192
Clifton-Hadley, Laura
D’Sa, Shirley
Pratt, Guy
Campbell, Gavin
Campbell, Lauren
Sadler, Ross
Townsend, William
Popova, Bilyana
Smith, Paul
Schofield, Oliver
Owen, Roger
Auer, Rebecca http://orcid.org/0000-0001-7169-7659
Funding for this research was provided by:
Cancer Research UK (C26303/A14139)
Article History
Received: 10 August 2023
Revised: 16 January 2024
Accepted: 19 January 2024
First Online: 26 February 2024
Competing interests
: LC-H has received funding (which in part pays staff salary) to Sponsor and coordinate clinical trials. Funding has been awarded/used in the last 2 years from Millennium pharmaceutics inc., Bristol-Myers Squibb Pharmaceuticals Ltd., Amgen GmBbH., Celgene Ltd., Merck Sharp and Dohme Ltd., Janssen-Cilag Ltd and Pfizer Ltd., SD’S has received research funds from BeiGene and Janssen-Cilag Ltd. and has acted on an advisory board and received honoraria from BeiGene, Janssen-Cilag Ltd and Sanofi, WT has received honoraria and consultancy fees from Roche, Gilead and Celgene, GC has received educational grants from Novartis and Bristol-Myers Squibb, RO has received honoraria from AstraZeneca and Celgene and has acted on an advisory board and received honoraria from BeiGene and Janssen-Cilag Ltd, RA has received consultancy fees from BeiGene and Janssen-Cilag Ltd. Funding has been awarded to support a clinical trial from Janssen-Cilag Ltd. No other authors declared conflicts of interest.